登录 | 注册 | 充值 | 退出 | 公司首页 | 繁体中文 | 满意度调查
综合馆
美国联邦政府食品药物管制的公共政策分析
  • 摘要

    美国近百年来关于食品药物管制的公共政策,经历了一个从以刚性规则和具有封闭性的FDA单一管制为特点的传统管制范式,向以合作、开放、信息共享、信息服务为特点的现代化-信息化管制范式转变的过程.这一过程可以分为管制的建立、管制的加强、管制的强化、管制的放松、管制的现代化-信息化五个阶段.其价值取向主要表现为优化管制方式、改变管制结构、加强管制责任、提高管制效率、注重信息开发和共享、强调提供全方位和高品质的公共信息服务,其政策措施则集中在转换管制范式、尝试间接管制、倡导自我管制、推行第三方管制与认证、开放管制程序、推进国际管制的和谐化趋势等方面.

  • 作者

    张国庆  李丹阳 

  • 作者单位

    北京大学,政府管理学院,北京,100871

  • 刊期

    2003年6期 PKU CSSCI

  • 关键词

    美国  食品药物管制  FDA  公共政策 

参考文献
  • [1] Russell S Sobel. Public health and the placebo: The legacy of the 1906 Pure Food and Drugs Act. CATO Journal, 2002,03
  • [2] McFadyen RE. Thalidomide in America: a brush with tragedy. ClioMed, 1976
  • [3] George C Eads;Michael Fix. Relief or Reform?Reagan's Regulatory Dilemma. Washington: The Urban Institute, 1984
  • [4] Clinton Bill. Statement on signing the Food and Drug Administration Modernization Act of 1997. Weekly Compilation of Presidential Documents, 1997,33
  • [5] O'Neill Robert T;Szarfman, Ana. Some US Food and Drug Administration perspectives on data mining for pediatric safety Assessment. Current Therapeutic Research, 2001,09
  • [6] Accessing the Food and Drug Administration: telephone or internet. Clinical Microbiology Newsletter, 2001,23
  • [7] Brimelow Peter;Spencer, Leslie. Food and drugs and politics (cover story). Forbes, 1993,12
  • [8] Fisher Lloyd D. Carvedilol and the Food and Drug Administration (FDA) Approval Process: The FDA Paradigm and Reflections on Hypothesis Testing. Controlled Clinical Trials, 1999,01
  • [9] Wilkenfeld Judith D. The food and drug adminis tration's regulation of tobacco products. Lung Cancer, 1997,18
  • [10] Roberts John. Food and Drug Administration un der assault. British Medical Journal, 1995,6972
  • [11] Antle John M. Benefits and costs of food safety regulation. Food Policy, ,06
  • [12] . http://www.fda.gov
  • [13] Beatrice Michael. FDA regulatory reform. Current Opinion in Biotechnology, 1997,08
  • [14] 植草益;朱绍文春;胡欣欣. 微观规制经济学. 北京:中国发展出版社, 1992
  • [15] Henson Spencer;Caswell, Julie. Food safety reg ulation:an overview of contemporary issues. Food Policy, 1999,06
  • [16] Vivian I Orlando. The FDA's Accelerated Approval Process: Does the Pharmaceutical Industry Have Adequate Incentives for Self-Regulation?. American Journal of Law and Medicine, 1999,25
  • [17] Shank Fred R;Bailey,Catherine J. Trends of FDA Resource Allocations over the Past 20 Years: Expected Future Resources and Workload. Regulatory Toxicology and Pharmacology, 1996,03
  • [18] Jeffrey E Shuren. The Modern Regulatory Administrative State:A Response to Changing Circumstances. Harvard Journal on Legislation, 2001,38
  • [19] Peter Barton Hutt. Philosophy of Regulation: Under the Federal Food, Drug and Cosmetic Act. Food and Drug Administration Sixteenth Annual Educational Conference (Washington), 1972
  • [20] Wolgemuth Richard L. Realizing the promise of the US food and drug administration modernization act. Clinical Therapeutics, 1998,20
  • [21] Frankel Mark S;Morris, Parisa. A view from the field on food and drug administration regulation:report of a 2002 survey of U.S.fertility clinics. Fertility and Sterility, 2003,05
  • [22] Roth Sanford H;Mackenzie, Allen. Drug Development, Guidelines, and the Food and Drug Administration. Annals of Internal Medicine, 1984,01
  • [23] Wax Paul M. Elixirs, diluents, and the passage of the 1938 Federal, Food, Drug and Cosmetic Act. Annals of Internal Medicine, 1995,06
  • [24] Henry G Grabowski;John M·Vernon. The Regulation of Pharmaceuticals. Washington: American Enterprise Institute for Public Policy Research, 1983
  • [25] Henry I Miller. To America's health--A Proposal to Reform the Food and Drug Administration. Standford:Hoover Institution Press, 2000
查看更多︾
相似文献 查看更多>>
54.163.19.57